In a groundbreaking move, Boston Scientific Corporation (NYSE: BSX) has recently announced its definitive agreement to acquire Axonics, Inc. (Nasdaq: NASDAQ:AXNX ), a pioneering medical technology company specializing in the development and commercialization of advanced devices to address urinary and bowel dysfunction. This strategic acquisition, valued at...
gonna watch out for this one, earnings catalyst should push this higher. tight stop loss, like the r/r here.
Hi, today we are going to talk about Axonics Modulation Technologies and its current landscape. Axonics Modulation is poised to receive increasing attention from the market as relevant events are taking place. The medical technology company announced that it received permission for nine patents related to its implantable sacral neuromodulation technology, which...